Login / Signup

Optimizing Hydroxyurea Treatment for Sickle Cell Disease Patients: The Pharmacokinetic Approach.

Charlotte NazonAmelia-Naomi SaboGuillaume BeckerJean-Marc LessingerVéronique KemmelCatherine Paillard
Published in: Journal of clinical medicine (2019)
It is urgent to be more efficient in the treatment of SCA, and pharmacokinetics can be an important asset in SCA patients.
Keyphrases
  • end stage renal disease
  • sickle cell disease
  • newly diagnosed
  • ejection fraction
  • chronic kidney disease
  • prognostic factors
  • peritoneal dialysis
  • combination therapy